MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$14.99 -0.20 (-1.32%)
As of: Sep 4, 2026 · 3:21 PM EDT

MoonLake Immunotherapeutics (MLTX) Goodwill & Intangibles (2020)

MoonLake Immunotherapeutics (MLTX) posted quarterly Goodwill & Intangibles of $5.0 million for Q4 2020.

Analysis

MoonLake Immunotherapeutics (MLTX) Goodwill & Intangibles (2020) Analysis & Trends

MoonLake Immunotherapeutics' Goodwill & Intangibles history runs 1 years deep, the most recent figure standing at $5.0 million for Q4 2020.

  • In Q4 2020, Goodwill & Intangibles changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2020 stood at $5.0 million (changed N/A YoY), while the FY2020 annual figure was $5.0 million, changed N/A from the prior year.
  • Goodwill & Intangibles for Q4 2020 stood at $5.0 million.
  • The five-year high for Goodwill & Intangibles was $5.0 million in Q4 2020, with the low at $5.0 million in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 MoonLake Immunotherapeutics 1.11 Bn 568.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 5.00 Mn